Synthesis, in vitro inhibitory activity towards COX-2 and haemolytic activity of derivatives of Esculentoside A

Bioorganic & Medicinal Chemistry Letters
2007.0

Abstract

Esculentoside A (EsA) has been reported to possess anti-inflammatory activity and selective inhibitory activity towards cyclooxygenase-2. A series of derivatives of EsA were synthesized by converting the C-28 carboxylic acid group into amides. The haemolytic activity and inhibitory activity towards cyclooxygenase-2 were evaluated in vitro. The SAR study of the derivatives was conducted and showed that introducing aromatic ring to EsA greatly enhanced its biological activity. Compound 23 showed higher inhibitory activity than Celecoxib and EsA, but lower haemolytic toxicity than EsA.

Knowledge Graph

Similar Paper

Synthesis, in vitro inhibitory activity towards COX-2 and haemolytic activity of derivatives of Esculentoside A
Bioorganic & Medicinal Chemistry Letters 2007.0
Design, synthesis and bioactivities of Celecoxib analogues or derivatives
Bioorganic & Medicinal Chemistry 2017.0
Selective COX-2 inhibitors. Part 1: Synthesis and biological evaluation of phenylazobenzenesulfonamides
Bioorganic & Medicinal Chemistry Letters 2006.0
Synthesis and biological evaluation of ester derivatives of indomethacin as selective COX-2 inhibitors
Medicinal Chemistry Research 2012.0
Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors
Bioorganic & Medicinal Chemistry 2011.0
Synthesis, biological evaluation and molecular docking studies of stellatin derivatives as cyclooxygenase (COX-1, COX-2) inhibitors and anti-inflammatory agents
Bioorganic & Medicinal Chemistry Letters 2011.0
New selective cyclooxygenase-2 inhibitors from cyclocoumarol: Synthesis, characterization, biological evaluation and molecular modeling
European Journal of Medicinal Chemistry 2018.0
New Celecoxib Derivatives as Anti-Inflammatory Agents
Journal of Medicinal Chemistry 2008.0
Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,3,5-triarylpyrazoline and 1,5-diarylpyrazole derivatives as selective COX-2 inhibitors
Bioorganic & Medicinal Chemistry Letters 2016.0
The antioxidant properties of salicylate derivatives: A possible new mechanism of anti-inflammatory activity
Bioorganic & Medicinal Chemistry Letters 2015.0